Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adagio Therapeutics Inc (NQ: ADGI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adagio Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
IVVD FINAL DEADLINE MONDAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
From The Rosen Law Firm PA
Via GlobeNewswire
INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI
From Kahn Swick & Foti, LLC
Via Business Wire
NATIONALLY RANKED ROSEN LAW FIRM Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
From Rosen Law Firm
Via Business Wire
Adagio Pauses FDA Emergency Use Request For Its COVID-19 Therapy
Via Benzinga
Why Is Adagio Therapeutics (ADGI) Stock Up Today?
Adagio recently announced that lab data has proven the effectiveness of its antibody treatment. ADGI stock is up more than 40% on the news. 
Via InvestorPlace
Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop
From Invivyd
Via GlobeNewswire
Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer
From Invivyd
Via GlobeNewswire
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public... 
Via Benzinga
Adagio's COVID-19 Antibody Meets Primary Goals Across Pre & Post-Exposure Prophylaxis, Treatment
Via Benzinga
Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
Mithril Capital’s Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for Support of Successful Proxy Campaign
From Mithril Capital Management LLC
Via Business Wire
30 Stocks Moving In Monday's Mid-Day Session
Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday. 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million. 
Via Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) rose 33.3% to $1.92 in pre-market trading after the company reported Q4 EPS results up from last year and better-than-expected sales... 
Via Benzinga
51 Biggest Movers From Yesterday
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday... 
Via Benzinga
Mid-Afternoon Market Update: Dow Drops 100 Points; Adagio Therapeutics Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 100 points on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Adagio Therapeutics (NASDAQ:ADGI) shares rose 40.0% to $5.39 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 80.0... 
Via Benzinga
S&P 500 Set to Snap 4-Day Win Streak Despite Jobs Data
Stocks are still in the red this afternoon, though the major indexes have pared some of their pre-market losses on the heels of employment data. 
Via Talk Markets
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! 
Via InvestorPlace
MRNA Stock: What’s Going on With Moderna This Week?
Moderna (MRNA) stock is on the move this week after the CDC and the FDA updated their Covid-19 booster shot recommendations. 
Via InvestorPlace
SPCE Stock: What’s Going on With Virgin Galactic This Week?
Virgin Galactic (SPCE) stock has been on the upward trend this week and we're going over all the recent news affecting the shares. 
Via InvestorPlace
Mid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge
U.S. stocks traded lower midway through trading following the release of GDP data. 
Via Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales... 
Via Benzinga
Why Adagio Therapeutics Stock Is Soaring Today
Adagio Therapeutics Inc (NASDAQ: ADGI) is trading higher Wednesday after the company announced its investigational drug adintrevimab (ADG20) was the first monoclonal... 
Via Benzinga
Peering Into Adagio Therapeutics Inc. - Common Stock's Recent Short Interest
Adagio Therapeutics Inc. - Common Stock's (NASDAQ:ADGI) short percent of float has fallen 11.69% since its last report. The company recently reported that it has 5.28 million... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.